CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 11.05
  • +0.25+2.31%
Market Closed Nov 29 15:00 CST
4.84BMarket Cap345.31P/E (TTM)

Zhejiang Starry Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Starry Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
474.06M
--
-13.34%
EPS
--
-0.03
--
--
Analyst Rating
Strong Buy

Nov 30, 2024

Zhejiang Starry Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.240B--
--2024/FY-- / 2.633B--
--2023/FY2.196B / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.240B--
--2024/FY-- / 2.633B--
--2023/FY2.196B / 2.437B--
--2022/FY2.131B / 2.078B--
--2021/FY2.000B / 1.950B--

Unlock Free Earnings Estimates

Zhejiang Starry Pharmaceutical Earnings Reports

  • Stari: Stari\'s report for the third quarter of 2024

    Oct 30 12:00 ET

  • Stelli\'s report for the third quarter of 2024

    Oct 30 12:00 ET

  • The full text of Zhejiang Starry Pharmaceutical's 2024 semi-annual report.

    Aug 22 12:00 ET

  • Summary of Zhejiang Starry Pharmaceutical's 2024 interim report.

    Aug 22 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data